Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Popular, Inc. (BPOP) - free report >>
Subsea 7 SA (SUBCY) - free report >>
MAG Silver Corporation (MAG) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Popular, Inc. (BPOP) - free report >>
Subsea 7 SA (SUBCY) - free report >>
MAG Silver Corporation (MAG) - free report >>
Image: Shutterstock
New Strong Buy Stocks for May 19th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Subsea 7 S.A. (SUBCY - Free Report) : This company that delivers offshore projects and services for the energy sector has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 17% over the last 60 days.
Subsea 7 SA Price and Consensus
Subsea 7 SA price-consensus-chart | Subsea 7 SA Quote
MAG Silver Corp. (MAG - Free Report) : This precious metal company has seen the Zacks Consensus Estimate for its current year earnings increasing 18.3% over the last 60 days.
MAG Silver Corporation Price and Consensus
MAG Silver Corporation price-consensus-chart | MAG Silver Corporation Quote
Karooooo Ltd. (KARO - Free Report) : This company that provides mobility software-as-a-service (SaaS) platform for connected vehicles has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 7% over the last 60 days.
Karooooo Ltd. Price and Consensus
Karooooo Ltd. price-consensus-chart | Karooooo Ltd. Quote
Candel Therapeutics, Inc. (CADL - Free Report) : This clinical stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 17.9% over the last 60 days.
Candel Therapeutics, Inc. Price and Consensus
Candel Therapeutics, Inc. price-consensus-chart | Candel Therapeutics, Inc. Quote
Popular, Inc. (BPOP - Free Report) : This retail, mortgage, and commercial banking products and services company has seen the Zacks Consensus Estimate for its current year earnings increasing 4.8% over the last 60 days.
Popular, Inc. Price and Consensus
Popular, Inc. price-consensus-chart | Popular, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.